Rhythmic tibial compression boosts survival from 20% to 90% in mouse TBI models via PIEZO1

Researchers induced TBI and stroke in mice and pigs, then applied 300-400 cycles daily of controlled tibial compression using ElectroForce devices. In mice, this reduced neuronal loss, lowered chronic microglial activation, and increased hippocampal neurogenesis; pigs showed extended median survival by five days. The effect required PIEZO1 channels in osteocytes, establishing a mechanical bone-to-brain signaling route. Observational data already link concurrent fractures to faster callus formation after TBI, suggesting endogenous extracellular vesicles from injured neurons may prime bone progenitors.

The protocol scaled force to body weight and produced consistent behavioral gains in pole and rotarod tests by day 7. No pharmacologic agent has yet replicated this breadth of recovery across motor, memory, and survival endpoints. The work reframes bone as an active participant rather than passive bystander in central nervous system repair.

Translation barriers remain substantial: anesthesia was required during loading sessions, and dosing parameters have not been optimized for awake humans. Next steps include testing non-invasive wearable actuators and confirming whether similar frequencies can be delivered safely in early-phase clinical protocols.